The secondary objective of the study was to assess bioequivalence between the new soft gelatin capsule formulation and a fast-dissolving ibuprofen lysinate formulation.

Bioequivalence between 200mg tablets of ibuprofen lysinate and a new 200mg soft gelatin capsule was demonstrated. In accordance with previous results, this study confirmed again the ...